Skip to main content
. 2020 Nov 18;46(12):2136–2152. doi: 10.1007/s00134-020-06296-9

Fig. 2.

Fig. 2

Kaplan–Meier survival curve censored at day 28 in HARP-2 stratified by phenotypes assigned using a 3-variable ancillary parsimonious model (interleukin-6, soluble tumour necrosis factor receptor-1, and vasopressor-use) and treatment (simvastatin or placebo). The variables selected in the parsimonious model were dictated by the availability of data. This figure was previously published in Lancet Respir Med [85]. Published with permission